Clinical trials
Phase 3 Obesity trials in Portugal
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2018 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 7 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Not yet recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 13 |
| Sanofi | 4 |
| Amgen | 2 |
| Eli Lilly and Company | 2 |
| Boehringer Ingelheim | 1 |
| Universidade do Porto | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 23 |
| Overweight | 7 |
| Diabetes Mellitus, Type 2 | 4 |
| Atherosclerosis | 1 |
| Bulimia | 1 |
| Cardiovascular Diseases | 1 |
| Dyslipidemias | 1 |
| Feeding and Eating Disorders | 1 |
| Heart Failure | 1 |
| Myocardial Infarction | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.